Podcasts about real chemistry

Maybe the biggest news to come out of PRWeek's Agency Business Report 2025 was that Real Chemistry supplanted Edelman as the No. 1 PR firm in the U.S. by revenue for 2024. Real Chemistry CEO Shankar Narayanan talks about that honor, and what the disposal of specialist shop Swoop will mean for his firm, on the latest edition of The PR Week podcast. He also previews Real Chemistry's presence at the Cannes Lions International Festival of Creativity, talks about how nearly all of his firm's work is rooted in communications and discusses what happens when large organizations combine — spoiler: they don't become more creative. Plus, the biggest marketing and communications news of the week, from the opening honorees on PRWeek's Pride in PR list to McDonald's chief impact officer Michael Gonda's new job at Nike.   Follow us: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

“Writing steamy scenes is easy—it's getting my characters to talk afterward that's the hard part.” In this episode of the Fresh Fiction Podcast, Samantha Tennant sits down with fan-favorite romance author Jade Lee—also known as Kathy Lyons—to talk all things love, laughter, and literary scandal! We're diving into THE DUKE'S GUIDE TO FAKE COURTSHIP, a Regency romance that's full of witty banter, unexpected twists, and a deliciously slow-burn love story you won't want to miss. Jade shares how she brings humor and heart to historical fiction, her favorite tropes to write, and the secret behind creating irresistible chemistry between characters. Whether you're a longtime fan or just discovering her books, this episode is packed with insights, laughs, and bookish joy.  Tune in, subscribe, and don't forget to tell your fellow romance readers!  Find more great reads at FreshFiction.com

Introducing Live from SXSW - The Future of Scientific Communications Through Podcasting from Science Will Win.Follow the show: Science Will WinPodcasting has become essential for communicating breakthroughs in science, offering an accessible and engaging platform to reach diverse audiences. This evolving medium fosters deeper connections by delivering trusted information in accessible and compelling ways. In this conversation, audio makers from Pfizer, Acast, and TED, discuss what it takes to stand out in the science podcast space, insights on strategy, and how they're working to shape the future of health communication.Moderator• Aaron Strout, Former CMO of Real Chemistry and Health PodcasterSpeakers• Erica Santiago, Executive/Digital Communications & Podcast Strategy, Pfizer• Veronika Taylor, SVP of Acast's Creator Network• Shoshana Ungerleider MD, Host and Producer of TED Health PodcastThis episode was recorded live in Austin, TX on Monday, March 10, as part of Pfizer's takeover of the South by Southwest podcasting lounge.Please fill out our short survey so we can get to know our listeners better: pfizer.com/podcastsurvey DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Welcome to S3E05 of IMpulse, the Influencer Marketing Podcast! In this episode, we're joined by Aaron Strout, former Chief Marketing Officer at Real Chemistry, a global health innovation company that's transforming how healthcare brands tell stories using data, digital innovation, and AI. Aaron dives deep into the impact of AI on marketing, from influencer vetting and brand safety to content personalization and campaign optimization. He talks about why human oversight still matters in an AI-first world, how to spot hallucinations in generative tools, and what “agentic search” means for influencer discovery. Plus, he shares his bold 2030 prediction for AI's role in marketing and how brands can stay authentic without losing creative momentum.

Gary Welch is a medical illustrator and animator based in Philadelphia. A graduate of the RIT program, Gary has worked at 3FX, MadMicrobe, and is now Production Supervisor at Real Chemistry. Show notes: https://www.pkvisualization.com/post/mip-gary-welch-interview

Ben Chapman is the General Counsel and Chief Privacy Officer at Swoop. Prior to Swoop, Ben was the Deputy General Counsel for Real Chemistry. He has nearly 10 years of experience in ad tech, data, and privacy matters. In this episode… Companies that operate in the healthcare marketing space, like Swoop, approach privacy by emphasizing transparency, ethical practices, and building trusted partnerships. To remain compliant, businesses need to thoroughly understand their data handling processes and regularly assess their partners. By asking detailed, factual questions, companies can make informed decisions about their partners' practices and ultimately strengthen their privacy programs. Additionally, adopting a consumer- or patient-centric perspective helps businesses navigate the complexities of privacy laws while aligning with regulatory requirements and ethical standards. A proactive and well-informed approach to privacy strengthens compliance efforts and builds trust. Healthcare marketing faces new challenges as privacy laws evolve and health data definitions expand. Laws like the Washington My Health My Data Act broaden the scope of what constitutes health data, requiring organizations to reevaluate how they handle consumer data. Navigating this complex regulatory landscape requires companies to ensure compliance with state privacy laws and federal regulations like HIPAA, all while maintaining trust and transparency with consumers. How can companies ensure ethical and privacy-friendly marketing practices? In this episode of She Said Privacy/He Said Security, Jodi and Justin Daniels speak with Ben Chapman, General Counsel and Chief Privacy Officer at Swoop, about the intersection of privacy and healthcare marketing. They discuss how state privacy laws redefine health data, the importance of ethical data practices, and strategies for evaluating partners. Ben shares his insights on building privacy programs, fostering collaboration, and navigating the nuances of healthcare marketing in a highly regulated environment. He also highlights the importance of continuous learning and collaboration within the privacy community to stay ahead in the ever-changing regulatory environment.

In this episode of Harmony Talk, Todd Stephens interviews Jim Weiss, Founder and Chairman of Real Chemistry, a global marketing and communications firm focused on the healthcare industry. Jim discusses the vital role of communication in healthcare, his journey from corporate life to entrepreneurship, and the importance of mentorship and giving back to the community. He shares insights on leadership, the influence of his small-town upbringing, and his aspirations for the future. Key Takeaways: Real Chemistry helps organizations tell their story effectively. Communication is a key component of leadership. Jim Weiss transitioned from corporate roles to entrepreneurship. Mentorship played a significant role in Jim's career. Growing up in a small town shaped Jim's values and work ethic. FOLLOW HARMONYTALK PODCAST @harmonytalkpodcast Join Our Mailing List: https://www.harmonytalkpodcast.com/signup Instagram: https://instagram.com/harmonytalkpodcast Facebook: https://www.facebook.com/harmonytalkpodcast YouTube: https://youtube.com/@HarmonyTALKPodcast LinkedIn: https://www.linkedin.com/company/harmonytalkpodcast https://harmonytalkpodcast.com/ Follow Host, Todd Stephens: https://www.instagram.com/workinman1/ Email harmonytalkpodcast@gmail.com for sponsorship and guest opportunities! See omnystudio.com/listener for privacy information.

Send us a textIn this episode of Transcending Home Care, Tony Kudner talks with April Dovorany, earned media expert at Real Chemistry, about sharing impactful patient stories. Learn how to craft pitches, engage local media, and navigate patient privacy to highlight the extraordinary care provided by home-based organizations while boosting visibility and community impact.

Welcome to our review of PR Pitches and mergers & acquisitions in the UK PR scene with Andrew Bloch. Here we discuss the biggest pitch wins and mergers & acquisitions that the PR sector has seen in 2024.If you haven't heard already I'm pleased to say we've now launched our PR Masterclass: The Intersection of Data, Planning and Measurement event. Attend this PR Masterclass to hear from experts on the latest techniques, tools and case studies about the use of data in modern communications.The other big news in public relations is that the PRmoment Awards 2025 are open. The final entry deadline is on January 17th. Miss it and miss out!Also, thanks so much to the PRmoment Podcast sponsors the PRCA.JANUARYPitchesIceland appointed TangerineHenkel appointed BCW/BursonMinistry of Justice appointed KindredAirbnb  appointed The Romans.M&AMerger of BCW and H+K to become Burson and create a £1bn + agency.Bully Pullpit Interactive acquired Boldt. FEBRUARYPitches“This is often the hangover from the Golden Quarter Pitches that start to get announced.”Bolt appointed Boldspace.Burger King appointed The Academy.British Gas appointed Smarts. M&A SEC Newgate acquired a 70% stake (over 5 years) in Athens HQ V+O Group.Real Chemistry acquired Avant Healthcare -Havas acquired Ledger Bennett. MARCHPitchesPepsi appointed Hope & Glory.“The first change for Pepsi in 14 years. This was a big big brief.”Taco Bell appointed Earnies.“You never forget your first win'Pizza Express appointed Pretty Green. M&AMHP acquired La Plage (creative content above the line agency). First acquisition for MHP since its acquisition by Next15.W acquired Franses,Havas appointed WildernessAPRIL PitchesWilliam + Grant appointed Exposure.Shark Ninja appointed  BursonTinder appointed The AcademyCarlsberg appointed Hope&GloryEA appointed Premier.M&AAccenture bought Unlimited“In my mind one of the smartest deals that was done this year.”WPP announced that leading global investment firm KKR has made a growth investment in FGS Global.“WPP has focused on releasing cash and consolidation and they've done that impeccably well.”“The holding companies and the big private equity firms have all realised that scale is important.”MAYPitchesEDF appointed Tin Man/Lucky Generals“What we've seen in consumer PR is... the agencies who went into the year strongest, have come out even stronger.”Reebok appointed Brand Nation.Pringles appointed Mischief MHP.Unilever appointed Golin“Nothing beats the UK, no one comes close, in terms of strategic creativity.”M&APagefield sells to PPHC.JUNE/JULYPITCHESFamous Grouse appointed Pretty Green.B&Q appointed Romans.Homebase appointed Aduro.The Independent appointed W.WRAP appointed Kindred.National Grid appointed 9 agencies to a “Community Agency Framework” for next 3 years – Grayling, Cavendish, Lexington, Aecom, Arup, Camargue, Copper, grasshopper, JBP.M&APublicis acquired Influential.Havas - acquired a controlling stake in Klareco Communications.Prime Weber Shandwick – MBO. AUGPITCHESMoet Hennessy appointed Earnies - wines and spirits division of LVMH.Dept for Education appointed FourArla Foods -appointed City Press.  

This show is going to be a little bit different because what we're going to do today is offer some advice to those who may work at a pharma company. But before we get into this advice portion of the discussion, let's start here. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Probably we're gonna have people listening to this episode who maybe are not in our normal tribe of Relentless Health Value listeners. While there are, for sure, regular listeners who work at pharma companies, there might be some newbies on the scene here. And to you, I say welcome. I hope that you feel right at home here. You know what, though? Many of us, including myself often enough, are slightly uncomfortable. Because this is the place where we all kind of look at ourselves in the mirror. We all live in glass houses, after all—everyone in the healthcare industry. There's no devils and no angels here. And the trick is maximizing the good and minimizing the not so good so that we all wind up with the highest net positive possible for patients. So, around here, we do not shy away from saying what needs to be said so that we all can find a way forward to serve the patient. We cannot solve problems, after all, that we have not taken a cold, hard look at. Yeah. So, today I am speaking with Brian Reid. I have been very much looking forward to speaking with Brian Reid, who many may know from his really great newsletter and really insightful LinkedIn posts. Brian Reid's advice, which he delivers in the episode that follows in sum. Spoiler alert here, but I also will say that he is much more eloquent than me, and the nuances are a thing. So, please do listen to the whole show. But Brian's piece of advice number one for Pharma (and really any product or service frankly), but piece of advice number one is this: Get a really solid bead on what value means—not just to PBMs (pharmacy benefit managers) or contract pharmacies or wholesalers who are middlemen but to the ultimate purchasers, the ones whose wallets the money is actually coming out of to pay the bill. Meaning, plan sponsors, such as self-insured employers or unions, patients themselves or members, and taxpayers. Again, how does value accrue to the ultimate purchasers like plan sponsors, patients/members, or taxpayers? Everybody else in the drug supply chain, let's be clear, is in the middle pushing money around that came out of somebody else's wallet. These middlemen have their own interests that may, for sure, may or may not be aligned with the interests of the ultimate purchasers. Getting value realized by patients will depend on understanding what the value is to these ultimate purchasers and then not getting derailed by any middleman who may not be so aligned. As a sidebar on this number one piece of advice, the whole “what's your value” and influence coloring this value equation made by ultimate purchasers is the prevailing beliefs of these ultimate purchasers, relative to Pharma, how they perceive the pharma industry. Whether it's earned or not—and this is not what we're gonna discuss today—but earned or not, Pharma does not have a great reputation with these folks right now. And this matters. Brian has a lot to say on this topic, which is fascinating. So, you should listen. Number two piece of advice that Brian Reid delivers in the podcast that follows that we talk about: Consider inching into the fray around benefit design. Rightfully so, there's always a lot of talk about patient affordability at pharma companies; but if I was gonna point to one thing that impacts affordability more than anything else, it'd be benefit design. There's only a small, underfunded cadre right now of folks out there (Mark Cuban aside, actually); but there's only a really small number of folks who never have any money who are really helping plan sponsors understand the impact on patients of some of the choices that they are making. I mean, personally, I could think of 10 things to do right off the top of my head that could help plan sponsors not get inadvertently screwed in this realm alone, just thinking they're saving money when, in reality, they are harming patients and not saving money. There's probably a lot of opportunities to communicate these kinds of things that are really win-win collaborations. Number three piece of advice that we talk about in the conversation that follows with Brian Reid: Keep an eye on hospital consolidation and vertical integration in the payer space. Consolidation raises prices and impedes patient affordability. This is as per study after study after study. Consolidation raises prices and sometimes considerably. Here's a part B to this third piece of advice about consolidation. There's sometimes wild swings in prices at different large, consolidated health systems in the exact same geography. Listen to the show with Cora Opsahl (EP452) for more about how their health plan, as just one example, saved $30 million a year just pushing a huge expensive health system, consolidated one, out of their network and navigating patients to more affordable sites of care. This matters to pharma companies because hospital system prices are currently crushing in many areas of the country, really impacting patient affordability. But there are better or worse options from an affordability standpoint in some of these geographies. To state the obvious, if an infusion of the same drug costs 10 times more if a patient shows up in one care setting versus another, that latter place, not affordable for patients. And by the way, that is not hyperbole of any kind. There are plenty of examples where literally an infusion of the same drug, same dosage will cost 10 times more if a patient goes one place versus another. But, again, it's not affordable. The patient cost share might be 10 times higher if it's coinsurance, if the patient goes to that latter place. And that latter 10x more of the cost place also just added 10x the cost to the PAP program or the foundation debit column. All of this is really relevant to Pharma. And just to pile on here because now I'm on a roll, another reason why this matters, these striking price variations between care settings, if we're talking about product value, and if the price the patient or the plan sponsor is paying is 10x the cost of the ingredients, nobody's doing that math and separating out the cost of ingredients from the, you know, total cost of the infusion. It is one lump sum number. So, if we're defining value as outcomes divided by cost and now the cost to the plan sponsor is 10x, product value just got reduced by 10x. Just in case anyone is confused here, and you probably know this, but many forget that the whole ASP (average selling price) plus 6% provider reimbursement—so, if that's what you're thinking and you're wondering how the 10x transpires—that ASP plus 6% provider reimbursement is only for Medicare kinds of plans. Hospitals can and do negotiate much higher reimbursements for commercial plans, and those carriers that have commercial lines of business and also MA (Medicare Advantage) books of business even allegedly actually negotiate higher commercial reimbursements so that they can get lower Medicare Advantage rates. Right, and you can see why, because the MA dollars are coming out of their own capitated pockets, whereas the commercial rates are being paid for by the ultimate purchasers, the plan sponsors. Also mentioned in this episode are Reid Strategic; Mark Cuban; Cora Opsahl; Bruce Rector, MD; Shawn Gremminger; Nina Lathia, RPh, MSc, PhD; Autumn Yongchu; Erik Davis; and Marty Makary, MD, MPH. Additional related episodes: EP380 with Mark Miller, PhD, on pharma communications. EP371 with Erik Davis and Autumn Yongchu on buy and bill versus pharmacy bagging. EP426 with Nina Lathia, RPh, MSc, PhD, on cost containment versus value-based drug purchasing. EP435 with Dan Mendelson from Morgan Health on how employers should consider pharma purchasing. EP365 with Scott Haas on PBM contracts and drug rebates. EP293 with Dea Belazi, PharmD, MPH, from AscellaHealth on co-pay cards, co-pay accumulators, and co-pay maximizers.   You can learn more by subscribing to Brian's newsletter and by following him on LinkedIn.   Brian Reid has nearly three decades of experience in healthcare journalism, public affairs, and public relations with a specialty in explaining the economics of the healthcare system. He is the founder of Reid Strategic, a communications consultancy, and a senior fellow at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center. At Reid Strategic, Brian counsels industry leaders on the best way to communicate on complex policy, access, pricing, and reimbursement issues in ways that critical audiences can understand. Brian's core belief is that we can't build a better healthcare system until everyone understands the system we have today. Reid Strategic offers communications strategy and execution around corporate, brand, and policy challenges, from prelaunch approaches to lifecycle management. Prior to founding Reid Strategic, Brian built and led Real Chemistry's Value+Access Communications practice, the largest such group dedicated to issues of value. Brian has written extensively for a range of audiences. At Reid Strategic, he publishes the daily Cost Curve newsletter; and his past experience includes coverage of the health science/policy beat for Bloomberg News, creation of patient education materials for the National Institutes of Health, and features in publications ranging from the Washington Post to Nature Biotechnology to Men's Health. He has a bachelor's degree in biology and political science from Emory University and a master's degree from the Columbia University School of Journalism.   08:29 Why is it important to understand the term “value” in respect to medicine? 10:07 Why is it important to consider all the players affected by the idea of this “value”? 11:06 Who are the ultimate purchasers in Pharma? 12:23 Findings of the Kaiser Employer Health Benefits Survey. 14:52 Why does it matter that we consider what value looks like to all players affected by Pharma? 16:46 EP300 with Bruce Rector, MD. 18:38 EP448 (Part 1) with Shawn Gremminger. 20:04 What does Pharma need to do to showcase their value when PBMs are often “locked in” at the moment? 23:11 Why Brian is celebrating companies that put their prices in their press releases. 32:31 Why does Pharma have an obligation to explain their value? 33:16 EP426 with Nina Lathia, RPh, MSc, PhD. 33:39 Why is it important for Pharma to keep an eye on hospital monopoly behavior? 35:55 EP370 with Erik Davis and Autumn Yongchu. 37:44 Why Pharma needs to capitalize on alignment.   You can learn more by subscribing to Brian's newsletter and by following him on LinkedIn.   Brian Reid, of Reid Strategic, discusses #pharma and #patientaffordability on our #healthcarepodcast. #healthcare #podcast #financialhealth #primarycare #patientoutcomes #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Beau Raymond, Brendan Keeler, Claire Brockbank, Cora Opsahl, Dan Nardi, Dr Spencer Dorn (EP451), Marilyn Bartlett, Dr Marty Makary, Shawn Gremminger (Part 2), Shawn Gremminger (Part 1), Elizabeth Mitchell (Summer Shorts 9)  

Conversations around GLP-1s in today's healthcare market are mixed. Some stakeholders are thrilled with their potential, while others are filled with questions and even anxiety about how these powerful and popular drugs will impact their business. Many in the industry have been asking for months: “What can GLP-1s do?” But maybe this is the wrong question. Leaders should be asking “What CAN'T GLP-1s do?” To answer that question, live from HLTH 2024, host Rachel (Rae) Wood invites Rob MacNaughton, CEO of lifestyle intervention and obesity management organization Calibrate, Rita Glaze-Rowe, President at life sciences research organization Real Chemistry, and Dr. Spencer Nadolsky, lipid and obesity specialist and founder to break down the cross-industry perspective on GLP-1s and how the healthcare leaders should be thinking about both the potential and limitations of these novel therapies. In a market that is buzzing around the novel medications, these experts suggest a new focus on comprehensive weight management programs. Links: Treating Obesity At Scale: Real-World Outcomes Using Medication And Intensive Lifestyle Intervention | Calibrate Real Chemistry - AI and Ideas Transforming Healthcare Ep. 222: It's not just GLP-1s; here's what comprehensive weight management looks like Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs How 3 health systems provide comprehensive care for obesity 4 key elements of comprehensive obesity care (and how they look in practice) Join 165,000+ healthcare leaders and get the industry's most important news in your inbox—every day. What the 2024 elections mean for healthcare [Webinar, 10/24] How the 2024 elections could impact the healthcare industry A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

Want to know what it takes to create award-winning work in healthcare advertising? Check out our final Cannesplaining Healthcare podcast episode, live from the 2024 Cannes Lions International Festival of Creativity, featuring our 21GRAMS, a part of Real Chemistry, creative leaders as they explore the intersection of creativity, marketing and healthcare. Discover how to make your health advertising stand out with insights from Real Chemistry Chief Creative Office & 21GRAMS Managing Founder Frank Mazzola, 21GRAMS Executive Creative Director Lauren Polina, Chief Creative Officer Tom Richards and Executive Creative Director Chris Charles.

This PRWeek podcast, in partnership with Real Chemistry, takes a special look at healthcare and pharmaceutical communications, and the evolving role of AI tools in patient engagement and advocacy.This episode is in association with Real Chemistry Hosted on Acast. See acast.com/privacy for more information.

Listen to Jack O'Brien of MM+M and Brandon Pletsch, president of scientific visualization at Real Chemistry, as they delve into the dynamic intersection of art, science and AI innovation in the field of scientific visualization. During the interview, they will discuss the role of scientific art in communicating complex scientific ideas to key stakeholders, how AI has been integrated into this process and what the future may hold for scientific artists.Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

Join us to explore current trends impacting healthcare public relations, focusing on how these are shaping health equity initiatives, as well as traditional and digital media landscapes. Featuring expert insights from Real Chemistry thought leaders, you'll hear share actionable advice and innovative strategies to more effectively reach audiences and achieve communications milestones.Follow us: @PRWeekUS Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year's meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and future of the cancer experience. Touching on areas like advocacy, AI, screening and therapeutic advances, this can't miss conversation will help us envision a more effective and compassionate future in oncology.   The Art: The art of improving patient care. How industry collaborations, data-based messaging and campaigns and advocacy are helping to reach more patients earlier and more holistically. Ysabel Duron, Founder, President / Executive Director, The Latino Cancer Institute  Meredith Owen, Chief Revenue Officer, Analytics & Insights Group, Real Chemistry Shanthi Sivendran, MD, MSCR, MBA, Senior Vice President, Cancer Care Support, American Cancer Society    The Science: The latest therapeutics advancements in oncology. How technology is helping industry better engage providers and democratize science via visualization to help improve outcomes. HP Balaji, Senior Medical Director and TA Head, Bladder Cancer, Johnson & Johnson Innovative Medicine Brandon Pletsch, President, Scientific Visualization and Exhibit Experience, Real Chemistry

In this podcast, Larry Dobrow, executive, MM+M joins Nathan Minnich, SVP, Treace Medical and Real Chemistry's Brian Schwartz, chief growth officer, to discuss using creative minds, AI and analytics to inform fully integrated campaigns that are hyper-targeted, a little quirky and most importantly — attention-grabbing. Advertising elicits emotion. How do you strike the right balance between empathy and education when you have a short window to reach your audience? Hear from the experts. Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

In this episode of the Women Physicians Lead podcast, host Dr. Lisa welcomes Mary Stutts, CEO of the Healthcare Businesswomen's Association. Mary Stutts shares her experiences and insights on advancing women in healthcare leadership. She discusses the importance of diversity and inclusion, addressing the "broken rung," "paper ceiling," and "concrete ceiling" that hinder women's career progression. Stutts also highlights health equity, the impact of menopause on senior women leaders, and the potential of AI in healthcare. She urges women to advocate for themselves and stresses the need for companies to support women's advancement to ensure gender equality in the workplace. Introduction (00:00:00) Introducing Mary Stutts and her role as CEO of the Healthcare Business Women's Association. Mary Stutts' Leadership Journey (00:01:13) Details of Mary Stutts' extensive leadership experience in various organizations and her expertise in health equity. Influences on Pursuing Leadership (00:03:25) Mary Stutts discusses her career journey and the influential figures who supported her transition into healthcare leadership. Transitioning Between Roles (00:07:03) Mary Stutts shares her experiences of transitioning between different roles in the healthcare industry and the importance of proactive decision-making. Health Equity and Corporate Social Responsibility (00:18:35) Discussion about the importance of incorporating health equity into diversity and inclusion programs for better employee engagement and success. Strategic Leadership Experiences (00:22:46) Importance of gaining specific leadership experiences, including managing a P&L, mentoring, and job rotations, for women to become strategic leaders. Advocacy for Women CEOs (00:23:57) Mary's proactive approach in advocating for roles, including creating a health equity practice at Real Chemistry and her involvement with the Healthcare Business Women's Association (HBA). CEO Role at HBA (00:28:24) Mary's approach to her role as CEO at HBA, including conducting a listening tour, identifying priorities, and planning a strategy stretch for the organization. Supporting Women in Leadership (00:36:46) Mary's thoughts on how organizations can rally around women to support their leadership development and increase the pipeline of women serving in leadership roles. Recruiting, Developing, and Retaining Women in the Workplace (00:36:46) Importance of companies being intentional about recruiting, developing, retaining, and promoting women in decision-making roles. Hiring More Women of Color and Breaking the Concrete Ceiling (00:39:06) Urgency to hire more women of color, particularly black, Latino, and Asian women, and the difficulty women face in breaking through to the first director-level job. Health and Wellness in C-Suite Roles (00:41:39) Discussion about the physical and mental health challenges faced by senior-level women and the importance of self-care. Empowerment and Networking for Women (00:47:25) Importance of remaining diligent, aware, and fostering strong relationships and networks to empower women personally and professionally. Let's Connect! If you're navigating the choppy waters of a career transition or seeking support as you step into a leadership role, I'm here for you. Schedule a career transition discovery call with me here, and let's chart a course to your dream destination.

Welcome to our February 2024 Review of PR Pitches and mergers & acquisitions in the UK PR scene with Andrew Bloch, where we will discuss the biggest, most seismic pitch wins and mergers and acquisitions that the PR sector has seen in 2023.Andrew is the lead consultant - PR, Social, Content and Influencer at the new business consultancy firm AAR and a partner at PCB Partners, where he advises on buying and selling marketing services agencies.Andrew was also co-founder and managing partner at PR agency Frank, before stepping back in 2020 to found Andrew Bloch & Associates.A quick mention about the relaunch of PRmoment. If you take a look at PRmoment.com, you'll see a brand new design with lots of new features, hopefully, easier navigation and also the launch of our new subscription training service for senior folks within agencies' PRmoment Leaders. Do take a look and let us know if you like it.Thanks also so much to the PRmoment Podcast sponsors the PRCA.2 mins Andrew talks us through this month's biggest PR pitch wins in the UK:Tortilla, the Mexican fast food restaurant,  appoints PR agency Houston.Orlebar Brown - a luxury swimwear brand owned by Chanel - appoints PR agency W.Bolt appoints PR agency BoldspaceBurger King appoints PR agency The AcademyVersuni (Philips brand owner) appoints PR agency Smoking Gun.(Ketchum continues to partner with Philips. Tin Man continues to handle global comms.)Heineken's trade PR goes to food and drink  PR specialist Fleet StreetBallantines Whisky appoints Pangolin on a global brief.M&C Sport and Ents retain the global music brand strategy brief and Firstlight Group handle corporate comms.Four Seasons appoints Red - replaces PRCO after a 30-year client-agency relationship.Greggs appoint That Lot for a social media brief.Santander appoints two agencies - Lansons Team Farner for its consumer PR and MHP for its public affairs work.eToro appoints Lansons/Team Farner on a combined corp and brand brief.British Gas appoints Smarts for a consumer PR brief. (Working alongside BCW)“If there is a lack of long-term client commitment you have to adjust your cost base accordingly. The great agencies do that.”“We don't do this for fun. There is no point running an agency that doesn't make any money.”16 mins Andrew talks us through February's M&A activity:Faith Brand Communications is acquired by Fantastic MediaSEC Newgate acquires a 70% stake (over five years) in Athens HQ V+O Group.Real Chemistry acquires Avant Healthcare.Havas acquires b2b marketing specialist Ledger BennettCognito, an independent global PR agency, has completed the majority acquisition of its German operation Cognito DACH.

Jim Weiss has evolved Real Chemistry from a one-person consultancy into an international leader in health innovation. Currently, he serves as Chairman and Founder and as Executive Advisor to New Mountain Capital, Real Chemistry's investment partner. Jim is a healthcare, biopharma, medical tech entrepreneur, business leader, and digital health pioneer. He's been named a Top 50 Health Influencer and Innovator of the Year. Last year, he received the Trailblazer Lifetime Achievement Award.  His affable curiosity began in our hometown of Honesdale, Pennsylvania, and was furthered at his alma mater, Syracuse University, where he was inducted into the Newhouse School's 50 Forward as one of its most accomplished graduates of the last 50 years. Jim and his wife Audra also founded the Weiss Center for Social Commerce at S.I. Newhouse School of Public Communications. In this episode, Jim talks with Todd Stephens about taking the leap from big pharma to launching a start-up. He recounts his early days becoming the leader that, perhaps, no one saw coming. He also touches on the next phase of his career. Through it all, Jim says his commitment to family and giving back kept him grounded. Still, he dispels the myth of work-life balance. He believes the pursuit of “downtime” and "work time" will usually merge. When he's not working, he loves to watch his Northern California teams and listen to The Grateful Dead or see Dead and Co. live! Jim resides with his wife and two children in the Bay Area.  See omnystudio.com/listener for privacy information.

In this episode, Suzanne Jacobs, Group President of Medical at Real Chemistry, and Trina Stonner, President of Avant Healthcare, discuss Real Chemistry's newly announced acquisition of Avant Healthcare, how the two companies came together and have similar ethos of supporting physicians in advancing patient care, and how the future of medical communications will involve a combination of data, creativity, AI, and human expertise. 

This episode of Moving Forward, Giving Back features the “Reputation Reboot: Steps to Restoring Public Trust in the Biopharma Industry,” panel discussion that took place at the JP Morgan Healthcare Conference on January 9th in San Francisco. The panel brought together several industry heavy-hitters to tackle how we can enhance trust by demystifying our work, sharing empathy and information, and providing opportunities for communities to engage. Introduced by Rob Perez, the Founder and Chairman of Life Science Cares, and moderated by Jim Weiss, the Founder & Chairman of Real Chemistry, the panel includes Ted W. Love, the Chairman of BIO, Julie Gerberding, CEO of the Foundation for the National Institutes of Health (FNIH) and California State Senator Josh Becker.The esteemed group of executives have a multifaceted, dynamic discussion about the general public's perception of the life sciences industry today, the need to increase general awareness of the industry's positive activities in local communities, the importance of actively connecting with all levels of government, as well the impactful actions that organizations like Life Science Cares are doing both locally and nationally. 

In this podcast, we'll bring together three of the PRWeek Health Influencer 30 winners to discuss the importance of healthcare communications and outline key themes for healthcare communicators leading into 2024.Follow us: @PRWeekUS Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

It's time to talk about cancer prevention and early detection. Join us as we explore the importance of early detection and prevention in the fight against cancer with Dr. Karen Knudsen, CEO of the American Cancer Society, and Jim Weiss, Founder and Chairman at Real Chemistry. Tune in to learn about the role of the American Cancer Society in research, advocacy and patient support, the importance of genetic testing in understanding cancer risk and the future of cancer testing and the role of AI.

Listen to our latest podcast with Peter Lee, Corporate Vice President of Research and Incubations at Microsoft, and Brandon Pletsch, Practice Leader of Scientific Visualization at Real Chemistry, to learn about the applications and implications of generative AI, specifically GPT-4, in healthcare and other fields. They explore public perceptions of AI, its potential benefits and risks, the importance of ethical considerations and regulatory guidelines, and the concept of equitable access to AI in healthcare. Check out the episode to gain insight into how AI can revolutionize fields outside of human language and thought.

In this episode of the Data Malarkey podcast, data storyteller Sam Knowles is joined by Shai Reichert, Co-Founder of XDS – a US-based business also known as the Experience Design Studio. Shai has almost 20 years' experience working in web development, user and customer experience. He has held senior roles on both the client side (for Comcast and Rosetta) as well as in digital marketing agencies. Shai spent six years in charge of all things technological at the specialist healthcare agency the W2O Group – now known as Real Chemistry.   Half-a-dozen years ago now, Shai co-founded XDS, where he focuses on the technology and operations necessary to build a positive and robust customer experience for its clients, which are mostly active in healthcare. XDS offers a heady mix of consulting, design thinking, engineering, marketing, and analytics. The company aims to enhance the customer – or patient – experience ‘beyond the pill' for pharma and healthcare companies.   Our conversation was recorded remotely, via the medium of Riverside.fm, on 19 April 2023.   Thanks to Joe Hickey for production support.   Podcast artwork by Shatter Media.   Voice over by Samantha Boffin.   As a sports fan – to play, to watch, and to encourage his sometimes reluctant kids to take part – Shai spends a fair amount of his time outside of the office with his head deep in sport. That includes in the data surrounding sport – particularly his favourite, baseball – though he baulks at the real-time application of the Moneyball principles. Particularly if that means taking off a pitcher when he's only pitched a few balls because the next three at-bat have a great record over him. That's a bit much.   Shai's agency, XDS, makes extensive use of data to understand how its clients are performing in their digital marketing channels, learning from data how they could improve performance, and monitoring it for evidence of impact. XDS helps clients enhance analytics, web traffic, search engine optimisation, paid ads – all different components of digital marketing spend.   The company was founded pre-pandemic, but on principles and ways of working – it turns out – that were perfectly suited for a locked-down world. XDS associates are spread across the US and, even when team members travel overseas, Shai observes that “they never miss a beat”. He goes on: “COVID accelerated a lot of things we were doing – on Slack, Teams and so on – and actually created a huge number of opportunities for us and our clients.”   Shai is lukewarm about the potential of mass-availability AI such as ChatGPT to transform marketing, but XDS finds it helpful in suggesting and elaborating copy and content strategy ideas. That said, Shai knows from experience that many businesses are not doing many of the seven critical website tactics he blogged about back in 2016, let alone embracing ChatGPT. EXTERNAL LINKS The XDS homepage – https://madebyxds.com Shai's LinkedIn profile – https://www.linkedin.com/in/shaireichert/ The evergreen, always-relevant post Shai first shared on LinkedIn on 4 January … 2016: “Forget 2016 ‘Digital Trends' – Here are 7 Website Tactics You Should Focus on Right Now” – https://www.linkedin.com/pulse/forget-2016-digital-trends-here-6-website-tactics-you-shai-reichert/ Shai on Twitter – https://twitter.com/thesreichert     To find out what kind of data storyteller you are, complete our data storytelling scorecard at https://data-storytelling.scoreapp.com. It takes just two minutes, and we'll send you your own personalised scorecard which tells you what kind of data storyteller you are.  

Learn more about the inspiring journey of Jason Gardner, Head of Medical at Real Chemistry, and his views on AI and DE&I in healthcare. From his father's struggle with multiple sclerosis to his strategic approach to medical communications, Jason shares his unique perspectives on how diverse thinking and experiences can bring value to the healthcare industry.

Today, we're thrilled to speak with Geoff Curtis, the former Executive Vice President of Corporate Affairs and Chief Communications Officer at Horizon Therapeutics. Before his impactful tenure at Horizon, Geoff was a senior vice president at Edelman Public Relations, leading media strategy and execution for a multitude of pharmaceutical, biotech, and medical device clients. His journey in the healthcare communications landscape spans over two decades, with notable roles at Real Chemistry, GCI Group, and the Pharmaceutical Products Division at AbbVie.In today's episode, Geoff details his extensive career journey from his early days in public relations and advertising to his pivotal former role at Horizon Therapeutics, a biopharmaceutical company dedicated to developing transformative medicines for individuals grappling with rare and rheumatic diseases. Geoff also illuminates the dynamic interactions between patient-centric approaches, corporate stewardship, and the challenges associated with the swiftly evolving healthcare landscape. Moreover, he shares his personal growth narrative, reflecting on how a three-day offsite event altered his outlook on feedback, propelling him toward seeking coaching to enhance his leadership acumen.Without further ado, please welcome Geoff Curtis, former Executive Vice President of Corporate Affairs and Chief Communications Officer at Horizon Therapeutics.-----Produced by Simpler Media

In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to break into the field.

In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden's Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical trials, the implications of the Inflation Reduction Act on the pharmaceutical industry and the influence of science in public health and policymaking.

In this three-part series, Real Chemistry's Shankar Narayanan (CEO) and Sim Simeonov (CTO) peel back the layers on the transformative effects AI can have – and is having – in healthcare. In addition to sharing their five-step framework for leveraging the latest advancements in AI in healthcare commercialization, these two leaders will also discuss how they're democratizing access to AI within Real Chemistry and explore how commercialization leaders can prepare their organizations to take better advantage of AI at every step.

Shankar Narayanan has been at the helm of one of the fastest-growing firms in the world, healthcare specialist Real Chemistry, since the start of the last year. The network has grown into one of the top three firms in the U.S. and six largest globally on the strength of its unique services. Narayanan talks about those, the economic environment, recent pitches and how his firm is embracing artificial intelligence. Plus the biggest marketing and communications news of the week, including:- Dave Samson's retirement- Real Chemistry hiring Steve Behm- The Women's World Cup- agencies' AI offerings and much more.  Follow us on Twitter: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

In this episode, Dr. Julie Gerberding, President and CEO of the Foundation for the National Institutes of Health (FNIH), Dr. Jay Bradner, FNIH board member and former President of the Novartis Institutes for Biomedical Research, and Jim Weiss, Founder and Chairman at Real Chemistry and FNIH board member, discuss the power of collaboration, how trust in science is essential for progress, emerging areas in medicine and the challenges of the current healthcare landscape. Listen to the full episode to gain valuable insights and to learn how FNIH is pioneering public-private partnerships to tackle complex health issues.

In this episode, Mark Martin, Managing Director at Houlihan Lokey, and Jim Weiss, Founder and Chairman at Real Chemistry, explore the healthcare marketing and commercialization industry, including the impact of data and technology, trends in acquisitions and deals, and the importance of organic growth and innovation.

This podcast features an interview with Larry Dobrow at MM+M and Real Chemistry's Frank Mazzola, Chief Creative Officer and Ari Srinivasan, Group EVP, Data & AI Solutions, to discuss how artificial intelligence and innovative ideas can work together to improve healthcare. Real Chemistry is a leader in this field, utilizing AI to develop data-driven insights about healthcare marketing. Through the combination of AI and creative ideas, Real Chemistry has been able to provide the best results for their clients, combining data-driven insights with creative ideas to create meaningful solutions. By bringing together the best of both worlds, Real Chemistry has been able to improve the standard of healthcare marketing. This podcast will explore the potential of AI and ideas and how they can work together to create the best possible outcomes within healthcare.

Avesta Rastan is a medical illustrator currently working as an associate art director for Real Chemistry. Avesta completed a Bachelor of Science with a major in life sciences and a minor in world languages from Queen's University, followed by a Master of Science in biomedical communications from the University of Toronto. Since graduating, Avesta has been exploring her field by working freelance and in industry roles, specifically at INVIVO Communications and now at Real Chemistry. In this conversation, Avesta tells us all about merging science and art through science illustration. She also discusses her journey of exploring her passions and discovering how to integrate them into her career. Tune in to learn all about it and connect with Avesta using the following links: Instagram: azuravesta.designTwitter: azuravestaLinkedin: Avesta Rastan Produced by Ment Projects. Follow us on @mentprojects on all social media platforms for updates and more mentorship resources. Visit our website to learn more about our mission and services. Episode Transcript 

Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and navigating challenging conversations. 

David Berkowitz is a serial marketer and has woven his experience as an employee, freelancer, and business owner into a successful career. In this episode, we talk about how David: Pivoted from cookie-cutter roles and was able to harness his experiences to create custom rolesContinually flexed his skills in fresh waysUsed his experience as a consumer and end-user to reverse engineer what marketers need to know Used a journalistic eye to keep his take on trends realistic and actionableAppreciates the importance of mentors, leadership, PR, and communications professionalsBelieves marketers need marketers and why he started the Serial Marketer CommunityUsed his strengths and intuition to refresh his career continuallyEpisode Guest: David Berkowitz founded the Serial Marketers community and the FOAF network for fraction-of-a-fractional CXO consultants. Previously, he held marketing and strategy leadership roles with omnichannel ad tech platform Mediaocean, video production marketplace Storyhunter, social listening firm Sysomos, Publicis agency MRY, and Dentsu agency 360i. He has contributed more than 600 columns to outlets such as Advertising Age, MediaPost, VentureBeat, and Adweek, and he has spoken at more than 400 events globally. He lives in midtown Manhattan with one daughter and two cats.Show notes: Serial Marketer CommunityFollow David Berkowitz on LinkedInFraction of a Fraction www.foaf.proThanks to Aaron Strout, CMO of Real Chemistry, for the episode title. Jill Griffin is on a mission to improve life in the workplace. Her executive coaching, strategy, and innovation have generated multi-millions in revenue for the world's largest agencies, start-ups, and well-known brands. She works with individuals, teams, and organizations to create cultures that allow leaders to increase performance while maintaining their well-being. Visit JillGriffinCoaching.com for more details on: 1:1 Career Strategy and Executive Coaching CEO Advising and Consulting Gallup CliftonStrengths Corporate Workshops to build a strengths-based culture Team Dynamics training to increase retention, communication, goal setting, and effective decision-making Grab an individual Strengths & Strategy Session with Jill Griffin HERE Follow @jillGriffinOffical on Instagram for daily inspiration.

With tools like ChatGPT and DALL-E dominating news cycles, many people – especially those working in creative jobs – are wondering if they will soon be replaced by the technology known as generative AI. During this session, originally recorded in front of a live audience at SXSW 2023, Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and Romain Bogaerts, Director of AI Product Management at Real Chemistry, discuss what impact generative AI is having on the creative process, particularly in the healthcare space. Who is using generative AI, and where do we see things headed over the next 6-12 months (or weeks?)

Today's episode is a recording of a SEVEN Talk from the 2022 Alumni Forum. This talk, given by Naimul Huq '08, is entitled, “The Un-blockable Chain.” Naimul is the senior vice president of operations at VaynerNFT, a Web3 consultancy.You can watch all of the SEVEN Talks on our YouTube channel. More about NaimulNaimul Huq '08 is the SVP and head of operations for Vayner3, a Web3 consultancy. Founded by entrepreneur Gary Vaynerchuk in 2021, Vayner3 guides enterprises, blockchain startups, and nonprofits into the next era of human interaction through NFTs, cryptocurrencies, mixed-reality experiences, and the use of decentralized protocols. Prior to his metaverse obsession, Naimul built the Data and Analytics practice at Precision Strategies, working alongside President Obama's former campaign managers on progressive political campaigns and international public affairs. In his free time, he was the CMO of RentCity, the first apartment-level review site in NYC. Before that, he led Analytics and Planning for Lippe Taylor Group, an award-winning media and advertising firm specializing in consumer brands. He honed his research and marketing interests over many years with Real Chemistry—a global PR agency focused on healthcare. After leaving Carolina pre-med with a bachelor's in English, Naimul worked in Humana's Innovation Center and realized the world-changing potential of Web 2.0 through the advent of social media. Naimul was raised in Omaha, Nebraska, where he waited for faster internet. You'll find him online at naimul.com. Naimul lives in Brooklyn with his wife, Neha, a pediatrician and so much more.How to listenOn your mobile device, you can listen and subscribe to Catalyze on Apple Podcasts or Spotify. For any other podcast app, you can find the show using our RSS feed.Catalyze is hosted and produced by Sarah O'Carroll for the Morehead-Cain Foundation, home of the first merit scholarship program in the United States and located at the University of North Carolina at Chapel Hill. You can let us know what you thought of the episode by finding us on Twitter or Instagram at @moreheadcain or you can email us at communications@moreheadcain.org. 

Howie Chan is a brand and marketing strategist focused on companies, products, and services that impact our health. He is the Principal and Founder of Healthy Brand Consulting, previously he was the Managing Director of Brand Strategy for Real Chemistry, an MM+M Gold winner for Large Healthcare Agencies. His experience is diverse within healthcare, having worked with startups and Fortune 500 companies, across medical devices, biotech, digital health, hospitals, payers, pharma, and consumer health brands. Howie lives in Minnesota with his wife and two kids, braving the winters and enjoying the lakes in the summer. What you will learn in this episode: What it means to be a healthy brand How finding your center can help you stay relevant without completely changing your company How the alignment of your values and your customers' values impacts your business Why your business needs to stick to one singular message to be memorable Howie's top questions to understand his clients' needs Resources: Website: https://www.howiechan.com/ LinkedIn Personal: https://www.linkedin.com/in/howiechaniam/ LinkedIn Business: https://www.linkedin.com/company/healthy-brand-with-howie-chan/ Facebook: https://www.facebook.com/howie.chan.31/ Twitter: https://twitter.com/howiechaniam

Annalisa Jenkins, MBBS, Non Executive Director at Compass Pathways & Jim Weiss, Founder and Chairman at Real Chemistry, join the podcast this week to discuss women in life sciences leadership roles, novel approaches to disease areas such as infectious diseases and cancer, and using AI for a more effective healthcare system.

Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine at the University of Oxford, and Jim Weiss, Founder & CEO of Real Chemistry, join this week's episode to discuss accelerating healthcare through novel ideas and the importance of collaborating across organizations, industries and countries. 

Gary Grates is a veteran in the world of communications, who has held numerous executive leadership positions at the top PR firms like Edelman, GCI, and Real Chemistry. He is a C-suite whisperer who has worked with the world's biggest brands like Pfizer, Merck, Genentech, HP, United Airlines and more. He was also the head of communications for General Motors North America. Gary is a speaker, writer, and professor at Syracuse University's Newhouse School of Public Communications. Today, he is the Managing Partner of Grates Consulting Group.Learn more about Gary:-        LinkedIn-        WebsiteTop 3 Lessons:1.     Communications will fail if it's just about communications2.     Start business transformation with the lens of the brand, not the business3.     Forget your job description to figure out the real problem to solveWays I can help you:Subscribe to Healthy Brand Mondays: 1 branding lesson every Monday in your inboxDownload free brand strategy guidesWork with me

Mary Stutts, Real Chemistry's Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.  -| The Health Equity Podcast Channel is made possible with support from Bayer G4A. Learn more about how Bayer G4A is advancing equity, access and sustainability at G4a.health -| This episode originally aired on October 13, 2022 on The Real Chemistry Podcast. Listen, follow and subscribe here.

Mary Stutts, Real Chemistry's Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.  -| The Health Equity Podcast Channel is made possible with support from Bayer G4A. Learn more about how Bayer G4A is advancing equity, access and sustainability at G4a.health -| This episode originally aired on October 13, 2022 on The Real Chemistry Podcast. Listen, follow and subscribe here.

The Dallas Mavericks have STILL only played 2 games but do Luka Doncic & Christian Wood have real chemistry? Will Facundo Campazzo play for the Mavs against the New Orleans Pelicans?Nick Angstadt (@NickVanExit) and Isaac Harris (@IsaacLHarris) discuss what they've learned about the Mavs so far this season, what to expect from Facu Campazzo who is now cleared to play, and more. What's one thing the Mavs will be able to sustain from this start? Then they grade your OVERREACTIONS from yesterday's show. Who overreacted and who underreacted?Subscribe to our Youtube Channel: Locked On MavericksFollow/Subscribe Anywhere: linktr.ee/LockedOnMavsFollow Locked On NBA: linktr.ee/LockedOnNBA Support Us By Supporting Our Sponsors! | Offers from our sponsors: lockedonpodcasts.com/offersBetOnline — Today's Episode is brought to you by BetOnline. BetOnline has you covered this season with more props, odds and lines than ever before. BetOnline – Where The Game Starts!LinkedIn — Today's episode is brought to you by LinkedIn. LinkedIn Jobs helps you find the qualified candidates you want to talk to, faster. Post your job for free at LinkedIn Dot Com slash LOCKEDONNBAPrizePicks — Today's episode is brought to you by PrizePicks. First time users can receive a 100% instant deposit match up to $100 with promo code LOCKEDON. That's PrizePicks.com – promo code; LOCKEDON Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Dallas Mavericks have STILL only played 2 games but do Luka Doncic & Christian Wood have real chemistry? Will Facundo Campazzo play for the Mavs against the New Orleans Pelicans? Nick Angstadt (@NickVanExit) and Isaac Harris (@IsaacLHarris) discuss what they've learned about the Mavs so far this season, what to expect from Facu Campazzo who is now cleared to play, and more. What's one thing the Mavs will be able to sustain from this start? Then they grade your OVERREACTIONS from yesterday's show. Who overreacted and who underreacted? Subscribe to our Youtube Channel: Locked On Mavericks Follow/Subscribe Anywhere: linktr.ee/LockedOnMavs Follow Locked On NBA: linktr.ee/LockedOnNBA   Support Us By Supporting Our Sponsors! | Offers from our sponsors: lockedonpodcasts.com/offers BetOnline — Today's Episode is brought to you by BetOnline. BetOnline has you covered this season with more props, odds and lines than ever before. BetOnline – Where The Game Starts! LinkedIn — Today's episode is brought to you by LinkedIn. LinkedIn Jobs helps you find the qualified candidates you want to talk to, faster. Post your job for free at LinkedIn Dot Com slash LOCKEDONNBA PrizePicks — Today's episode is brought to you by PrizePicks. First time users can receive a 100% instant deposit match up to $100 with promo code LOCKEDON. That's PrizePicks.com – promo code; LOCKEDON Learn more about your ad choices. Visit podcastchoices.com/adchoices

Investing in marketing and analytics is critical to navigating your organization successfully. Mark Stouse, Chairman & CEO of Proof, and Jim Weiss, Founder & Chairman of Real Chemistry, join the show to discuss this and the current state of marketing.

Mary Stutts, Real Chemistry's Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable. 

Making health information more approachable, simple and easy to understand will improve health literacy and ultimately improve patient outcomes. Dr. Geeta Nayyar, Chief Medical Officer of Salesforce, joins the show to discuss health misinformation and her takeaways from the Life Itself conference, plus she shares her love of U2. -| The Health Equity Podcast Channel is made possible with support from Bayer G4A. Learn more about how Bayer G4A is advancing equity, access and sustainability at G4a.health -| This episode originally aired on July 21, 2022 on The Real Chemistry Podcast. Listen, follow and subscribe here.

Abenaa is a 20+ year communications executive with a focus on Diversity, equity and inclusion (DEI) as well as healthy equity and social justice. She has been in senior leadership roles at agencies like MSL, Weber Shandwick, Edelman, and Real Chemistry where she counseled Fortune 500 companies on their DEI and thought-leadership efforts. She has since started her own firm, Elysee Consulting, specializing in this area. Learn more about Abenaa:-        LinkedIn-        TwitterTop 3 Lessons:1.     Address DEI challenges with purpose and intent2.     We can't “solve” DEI in a silo, it requires the entire organization3.     Being an ally in DEI requires that you learn more and speak outEpisode website URL:https://www.howiechan.com/blog/podcast-abenaahayes-ep3Ways I can help you:Download free guides (Healthy Brand Blueprint & Branding 101) to help you build healthy brandsWork with me as a fractional CMO/CBO or through Healthy Brand Consulting (Schedule a 15 min intro call)

Patients, caregivers, and their communities are at the center of our work, and nobody is a better advocate for these individuals than Sally Schaeffer our, VP of Community Engagement Strategy. In this episode, Sally tells her heartbreaking yet inspiring story of advocating for Sudden Unexpected Death in Epilepsy (SUDEP), learning how to be there for those experiencing grief, and sharing patients' authentic voices in health care communications.

The cancer landscape is evolving at record speed – and so too are the expectations and experiences of attendees at the annual ASCO (American Society for Clinical Oncology) meeting, held annually in Chicago from June 3-7. Join Real Chemistry's Jennifer Paganelli, Ujwal Pyati, and Brandon Pletsch, some our medical, media and creative experts, as they dissect trends shaping the optimal “art & science” approach to creating meaningful – and memorable – experiences at ASCO, the largest international cancer meeting of researchers, health care professionals, advocates and industry.

Real Chemistry's Chief Creative Officer Frank Mazzola sits down for a discussion with MM+M's Larry Dobrow to discuss how the future of health care hinges on a simple concept: connection. Frank will dive into the work Real Chemistry is doing to bring AI-based insights, conversation and creativity together, to connect with the audience and make medicine more inspiring than sneakers.

We're back with Dr. Monica Gandhi and our own Jim Weiss! We've loved checking in with these two about the current state of COVID-19, and this time, they delivered an uplifting assessment and a ton of recent data and studies to back it up.

About the Podcast The Stevens Group has been presenting the PR Masters Series Podcast for two years now.  This series is part of the ongoing partnership between The Stevens Group and CommPRO to bring to PR, digital/interactive and marketing communications agencies the wisdom of those who have reached the top of the PR profession.  Today's special guest is Jim Weiss, Chairman + Founder, Real Chemistry. When Art Stevens headed LobsenzStevens, a top independent New York PR agency in the nineties, his firm selected an up and coming young man as an intern.  That young man was Jim Weiss.  Jim was assigned to work on a healthcare account and that started his career in healthcare.  The rest is history.   About Our Guest Jim Weiss is the Chairman and Founder of Real Chemistry, a global health innovation company that uses real-world data, proprietary technologies and analytical insights to solve the health care industry's most significant challenges. He also serves as an Executive Advisor to New Mountain Capital, Real Chemistry's investment partner.  Jim evolved Real Chemistry from a one-person consultancy to a team of 1,800+ people who partner with clients at the highest levels of organizational decision-making. A pioneer in the application of analytics, data and precision targeting, Jim learned early in his career to follow the data to get to the right outcome.  He is also passionate about improving diversity, inclusion and health equity to make the world a healthier place for all.

About the Podcast The Stevens Group has been presenting the PR Masters Series Podcast for two years now.  This series is part of the ongoing partnership between The Stevens Group and CommPRO to bring to PR, digital/interactive and marketing communications agencies the wisdom of those who have reached the top of the PR profession.  Today's special guest is Jim Weiss, Chairman + Founder, Real Chemistry. When Art Stevens headed LobsenzStevens, a top independent New York PR agency in the nineties, his firm selected an up and coming young man as an intern.  That young man was Jim Weiss.  Jim was assigned to work on a healthcare account and that started his career in healthcare.  The rest is history.   About Our Guest Jim Weiss is the Chairman and Founder of Real Chemistry, a global health innovation company that uses real-world data, proprietary technologies and analytical insights to solve the health care industry's most significant challenges. He also serves as an Executive Advisor to New Mountain Capital, Real Chemistry's investment partner.  Jim evolved Real Chemistry from a one-person consultancy to a team of 1,800+ people who partner with clients at the highest levels of organizational decision-making. A pioneer in the application of analytics, data and precision targeting, Jim learned early in his career to follow the data to get to the right outcome.  He is also passionate about improving diversity, inclusion and health equity to make the world a healthier place for all.

Podcast topics:- Zeno Group wins three Kraft Heinz brand assignments;- Ongoing coverage of war in Ukraine, and the comms strategies of Volodymyr Zelenskyy and Russian propaganda; - Real Chemistry 2021 revenue surges to $439 million;- Weber Shandwick elevates Pam Jenkins to chief public affairs officer;- Details from PRWeek's inaugural Healthcare + Pharma Comms Awards shortlist;- PRWeek's 40 Under 40 is back and open for entries;- The reveal of this year's PRWeek Global Awards shortlist. Follow PRWeek on twitter @PRWeekUS

Our CEO, Shankar Narayanan, joins us for this week's show. He opens up about why he joined Real Chemistry and shares where the industry and our organization are headed.  Plus, he shares his ideal mixtape that will definitely give you earbud envy.

The global pandemic — that we're very much still immersed in — has put healthcare center stage. At this moment, we're seeing the complex interplay between health tech, providers, pharma, policy makers and other stakeholders on a global scale. It's both breathtaking and often bewildering. And even before 2020, healthcare was quickly becoming one of the most compelling areas for public relations. With that in mind, we partnered with Real Chemistry — formerly W2O — on a new series, Healthy Bites. In each episode, we will have a quick chat with a healthcare expert to provide a digestible "what you should know" to help the industry stay ahead of the rapidly changing healthcare public relations and communications landscape. And because healthcare touches every aspect of our lives these days, we hope these 10-minute conversations will be useful no matter what your day-to-day role is. In this episode, PRovoke Media senior reporter Diana Marszalek talks to Emily Poe, Real Chemistry's group president of integrated communications.

This week on Coffee Break, PRWeek editorial director Steve Barrett is joined by Art Stevens, managing partner, The Stevens Group.Stevens talks about the world of PR agency acquisitions — a hot topic right now — and what he is seeing in the marketplace. The interview includes advice for those considering selling their agency, the different types of deal, why deals can go sour and pitfalls to avoid, and more.Stevens has been a PR agency M&A consultant for 15 years, having sold his own firm — LobsenzStevens — to Publicis Groupe in 1999.Coffee Break topics:- About The Stevens Group and the role Art Stevens plays in the company.- How does a deal come about and what do you do for clients?- PR agencies' overall rise in business and the M&A market's impact- Private equity firms vs. PR agencies as buyers and how business is different - Biggest differences going with a private equity deal or going with an agency- Previous leaders staying on with a company after being acquired vs. new leadership- Pros and cons of a company making many acquisitions over a short window of time- Stagwell Group and Finn Partners investment- Real Chemistry's growth- What is the difference in doing business with major holding companies?- Tips for companies looking to sell and pitfalls to watch out for- How to not let being acquired overshadow the quality of your business and the attention you give clients

Explicit content: child death, sex trafficking, and other triggering conversationsI met Mary Stutts when she interviewed me for her book; The Missing Mentor; women advising women on Power, Progress, and Priorities. Mary Stutts is the Chief Global Inclusion & Health Equity Officer at Real Chemistry, Corporate Board Member, Author and Keynote Speaker. If you truly want someone who helps other women climb the ladder and someone who shows up - Mary is your woman. That's why episode 03 of How Women Inspire Podcast is about taking the shot with Mary Stutts! In this episode of How Women Inspire Podcast, Mary Stutts is sharing the importance of taking the shot and actionable steps you can take right now to acknowledge and understand your own biases and how to move forward with more equity. Some of the talking points Mary and I go over in this episode include:How Mary has found inspiration through Eminem and even wrapped her first C-suite speech, all through embracing fun, creativity, and the determination to seize every opportunity.How being in the foster care system encouraged Mary to use her voice and speak up, find her faith, and how influential her foster parents and faith have been for her story. Creating a path for inclusive leadership; how to implement the start of the change and how to make sure employees have the tools to change once biases emerge.How, and why, we need both patriarchal and matriarchal leadership styles to implement the best leadership and mentorship for those following us and working with us.This episode will help you not only live in a way that acknowledges biases, but you'll lead from a place of understanding and equity and teach others how to do the same. Thank you for listening!If you enjoyed this episode, take a screenshot of the episode to post in your stories and tag me!  And don't forget to subscribe, rate and review the podcast and tell me your key takeaways!CONNECT WITH MARY STUTTS:LinkedInCONNECT WITH JULIE CASTRO ABRAMS:LinkedIn - JulieHow Women LeadHow Women InvestHow Women GiveInstagram - HWLLinkedIn - HWLFacebook - HWLLINKS MENTIONED:Book: The Missing Mentor: Women Advising Women on Power, Progress and Priorities

The global pandemic — that we're very much still immersed in — has put healthcare at center stage. At this moment, we're seeing the complex interplay between health tech, providers, pharma, policy makers and other stakeholders at a global scale. It's both breathtaking and often bewildering. And even before 2020, healthcare was quickly becoming one of the most compelling areas for public relations. With that in mind, we partnered with Real Chemistry—- formerly W2O — on a new series Healthy Bites. In each episode, we will have a quick chat with a healthcare expert to provide a digestible "what you should know" to help the industry stay ahead of the rapidly changing healthcare public relations and communications landscape. And because healthcare touches every aspect of our lives these days, we hope these 10-minute conversations will be useful no matter what your day-to-day role is. In this episode, PRovoke Media senior reporter Diana Marszalek talks to John Capodanno, Real Chemistry's president of financial, corporate & capital markets communications. Topics covered: 01:40 Changes in corporate comms 03:44 Preparing for future challenges 04:31 The corporate comms skillset 06:22 Exemplary organizations 07:48 Reaching the c-suite

The importance of scientific communications has never been more evident as it is now. A major reason stems from the myriad comms pitfalls that appeared during COVID-19, particularly the early days.From real-time information challenges to opinions being misinterpreted as fact, Real Chemistry's Jennifer Gottlieb dissects the root of the COVID-19 comms problems that kept leaders such as her so busy from the get-go.When she confronts a particularly difficult scenario, one of the first questions she asks – Is this a crisis or a PR crisis? Knowing that answer impacts the response tremendously. This is just one of numerous bits of valuable counsel offered throughout the podcast.Aaron Rodgers. Healthcare choices made along political leanings. The important of “insight integration.” All these topics — and more — are tackled during Gottlieb's podcast with PRWeek managing editor Gideon Fidelzeid. We welcome you to listen in.

It's a family affair on this week's episode of the show! Our Global Head of Facilities, Beth Weiss, and Jim Weiss, our Founder, and CEO, join the show to chat about Beth's coming out journey and the importance of living as your authentic self.

Tune in to hear Chief People Officer, Steph Garcia, explain how Real Chemistry is leading the way in return to work strategy.

This week on the podcast, PRWeek editorial director Steve Barrett interviews Kristal Howard, director of media relations and corporate communications at Kroger and PRWeek's chair of jury for the 2021 Purpose Awards. Podcast topics: - Howard talks about how Kroger, the largest supermarket chain in the country, took steps to protect its employees during the COVID-19 pandemic and the importance of frontline essential workers in other industries from airlines to hotels;- Discussing the work of viral immunologist Dr. Kizzmekia Corbett, PRWeek's inaugural Purpose Awards Changemaker of the Year for 2021; - This year's Most Purposeful Activation winners, the Black Coalition Against COVID-19 and Real Chemistry and how they addressed COVID's disproportionate impact on Black communities across the country and vaccine hesitancy in communities of color; - Recounting other timely and important themes from the Purpose Awards, including combating skin cancer, food insecurity, gun violence, environmental protection, vioting rights and more;- The evolution of advertising and the PESO model of communications and how focused comms and drive purposeful change and reputational gains;- Recapping the PRDecoded Conference for 2021, the topic of which is "purpose transformed"; standout panelists including PepsiCo's Steven Williams, Pernod Ricard's Ann Mukherjee, and more.  

We've partnered with Real Chemistry— formerly W2O — on a new series Healthy Bites. In each episode, we will have a quick chat with a healthcare expert to provide a digestible "what you should know" to help the industry stay ahead of the rapidly changing healthcare public relations and communications landscape. In this episode, PRovoke Media executive editor Aarti Shah talks to Dan Carter, digital health and regional practice lead for the East Coast, about the future of digital health. Topics covered: 01:33 Defining digital health  02:26 The impact of recent VC investments in telehealth  05:13 How healthcare apps can stand out in such crowded markets    06:22 Will mental health continue to be digital-first?  08:29 Biggest digital health category in 2022?

It's been a long time coming, this in-person get-together of the three SmallDataForagers (I assume that's what you call someone moderating a forum?) to celebrate our Golden Jubilee. 1,955 days, in fact, since our fateful first encounter in the now sadly defunct Hospital Club in Soho. And nearly 650 days since our last Olivelli feast, just before Christmas 2019, when the world was a different, less pandemic place. That is of course all small fry compared with the 5,788 days that Angela Merkel has held the office of German Bundeskanzler. More of her and German politics later.    So, a long time coming, and well worth the wait: great company, inspiring conversations – the three of us don't just have now 50 SDF episodes to reminisce over, but also a shared professional history of one time (Sam, Thomas) and other (Neville) working in the London office of what is now Real Chemistry, a power house of digital analytics alchemy driven business insights in life sciences. As rebranding is such a thing, and in light of our professional interests (not least Sam's second book), perhaps we should start calling ourselves the SmallDataBigInsightsForum? Demonstrating resilient continuity in the face of pandemic disruption, we also reconvened at the Picturehouse Central members bar high above Piccadilly for one of those rare occasions, a live in-person podcast recording. Continue reading -> https://www.smalldataforum.com/ 

We've partnered with Real Chemistry— formerly W2O — on a new series Healthy Bites. In each episode, we will have a quick chat with a healthcare expert to provide a digestible "what you should know" to help the industry stay ahead of the rapidly changing healthcare public relations and communications landscape. We are launching the series with Emily Poe, group president of integrated communications at Real Chemistry, who talks to PRovoke Media executive editor Aarti Shah about data-driven communications.  Topics covered: 02:01 Defining data-driven communicator  02:59 The balance between instincts and data  03:53 Most exciting data-driven advancements  06:39 When does data have the most impact?

Value-based insurance design (VBID) uses incentives to increase health care quality and to promote cost efficient health care services and consumer choices. But like all approaches to health care cost containment, VBID isn't one-size-fits-all. For VBID to be effective—that is, promote high-quality services and discourage use of low-quality care—incentives must embrace clinical nuance, using data to assess how clinical benefits vary by person, provide and site of service. Leslie shifts from our typical “supply side” perspective to talk health care demand and how VBID engages consumers in their own health decisions with Christine Juday, Vice President at Discern Health, Real Chemistry's consultancy focused on quality-based payment and delivery models. For more news about VBID and other value-based delivery models, sign up for Real Chemistry's Quality Report newsletter. LINK:  https://www.w2ogroup.com/quality-report-newsletter/

She's back! Mary Stutts, Chief Global Inclusion & Health Equity Officer of Real Chemistry, joins the show again to discuss how to integrate health equity into everything you do.

Health data is medicine, according to Ardy Arianpour, CEO & Co-Founder of Seqster. Ardy is joined by Real Chemistry's Larry Mickelberg to discuss how we can break down health data silos and what that would mean for the future of healthcare.

Businesses can be a powerful force in health advocacy in their communities. Jim Weiss, CEO and Founder of Real Chemistry, breaks down how to effectively mobilize different population groups. The formula is simple: listen, get them answers, and let them make their own choices.

We can't undo 400 years of systemic racism in a week, creating equitable healthcare takes a movement not a moment. André Blackman, Founder & CEO of Onboard Health & Abby Hayes, Practice Leader of DE&I Engagement, Real Chemistry join this week's episode to discuss designing an equitable healthcare system.

New name, same ethos.

Could life have arisen from non-living chemicals via chemical evolution? If life couldn’t start by itself, then Darwinian evolution could not have started, therefore it is a fiction. This episode features Joel Tay and Dr Jonathan Sarfati. Creation.com Talk is produced by Joseph Darnell out of the CMI-USA studios. Become a monthly contributor at our donate page. You can also help out by telling your family and friends to check out Creation Talk. Helpful Resources Chemicals to Living Cell God the Master Designer By Design Evolution's Achilles' Heels (book & DVD) Links and Show Notes Origin of Life Questions and Answers Origin of life: the chirality problem Origin of life: the polymerization problem Origin of life: instability of building blocks 15 loopholes in the evolutionary theory of the origin of life: Summary Life from non-life (Creation Magazine LIVE! 3-14) Biological Robots FOLLOW US (if you want) ► Facebook ► Twitter ► Instagram ► Our site Photo by Terry Vlisidis on Unsplash Thanks for listening to the Creation.com Talk Podcast!

The Vaccine Confidence Project: How We Get from Shelter-in-place to Herd Immunity Listen in as two front-line leaders, Steve Madden, GM and Editor-in-Chief of MM+M and Jim Weiss, Founder and CEO of Healthcare Marketing and Communications firm, Real Chemistry, talk about: The state of the state – current vaccination run rates in the US and globally. Who is manufacturing what and how much? Which companies/organizations are doing a great job in building vaccine confidence? Bold predictions on what a return to normalcy looks like and when it might happen.

Empowering Queens --- Support this podcast: https://anchor.fm/coach-rod/support

To Purchase My Book Click On This Link.https://www.amazon.com/Queens-Dont-Settle-Roderick-Raysor/dp/B08KTWY4GL/ref=mp_s_a_1_1?dchild=1&keywords=queens+dont+settle+roderick+r+raysor&qid=1603755165&sprefix=queens+don&sr=8-1. For Coaching Click On This Link. https://mymentor.life/roderickraysor --- Support this podcast: https://anchor.fm/coach-rod/support